Penthrox approved in Sweden, Norway, Poland and Croatia
Filed with ASX · · 2 pages · English
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings CallMedical Developments International Limited on 6ix
Earlier from Medical Developments International
- Global demand for Medical Developments Shares
- Stage II success for new manufacturing technology- Lidocaine
- First Penthrox order for Austria
- Half Year Report and Accounts
- MVP signs major deal with Walgreens in the USA
Later from Medical Developments International
- Penthrox approved in Germany
- Penthrox is approved in Canada
- Penthrox Approved in Finland
- Trading Update
- Iran Distribution Deal and additional European Approvals
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International